疫苗接种建议和炎症性肠病的坚持:医生和患者的不和研究
Rocío Ferreiro-Iglesias1, Alejandro Hernández-Camba2, Antonio Valdivia3
1Department of Gastroenterology. Hospital Clínico Universitario de Santiago de Compostela, Santiago de Compostela, Spain; Health Research Institute of Santiago de Compostela (IDIS), Santiago de Compostela, Spain.
概括
在炎症性肠病 (IBD) 患者中,医生对疫苗的建议并不总是被患者回忆起. 改善沟通是提高这一群体疫苗接种率的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 胃肠病学 胃肠病学
- 公共卫生 公共卫生
背景情况:
- 炎症性肠病 (IBD) 患者的免疫率尽管有建议,但仍低于最佳水平.
- 医生对IBD疫苗的重要性的认识很高,但缺乏实施.
研究的目的:
- 评估IBD患者的疫苗接种管理.
- 探索医生建议和患者回忆这些建议之间的一致性.
- 为了评估患者在医生的建议下遵守疫苗接种.
主要方法:
- 匿名在线调查分发给8000名IBD患者 (ACCU西班牙) 和1000名医生 (GETECCU).
- 收集的数据是关于医生报告的建议和患者召回和遵守情况.
- 对各种疫苗类型的一致性和坚持率的分析.
主要成果:
- 有144名医生和1302名患者参与.
- 在怀孕期间医生报告的流感疫苗推 (69%) 和患者召回 (11.1%) 之间观察到显著的不一致.
- 接种疫苗的坚持程度各不相同 (HPV的55%,流感,肺炎球菌,乙型肝炎,结的80%以上),认为对不良事件的必要性和恐惧是主要障碍.
结论:
- 关于疫苗接种,IBD医生和患者之间存在沟通缺口.
- 医生意识很高,但有效的实施受到沟通障碍和患者报告的不遵守原因的阻碍.
- 需要改善医生与患者沟通的策略,以提高IBD患者的疫苗接种率.
相关概念视频
Inflammatory Bowel Disease III: Diagnostic Studies and Management I-Nutritional Therapy
987
Various diagnostic tests are employed in the diagnostic process for Inflammatory Bowel Disease (IBD), particularly to differentiate between Crohn's disease and ulcerative colitis.
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
Diagnostic studies
A colonoscopy is the definitive screening test, distinguishing ulcerative colitis from other colon diseases with similar symptoms. During a colonoscopy test, inflamed mucosa with exudate ulcerations can be observed, and biopsies are taken to determine the histologic characteristics of the...
987
Inflammatory Bowel Disease IV: Pharmacological Management
873
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...
873
Inflammatory Bowel Disease II: Crohn's Disease
1.4K
Introduction
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by...
1.4K
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
670
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab...
670
Inflammatory Bowel Disease I: Ulcerative Colitis
1.3K
Introduction
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
1.3K
Inflammatory Bowel Disease V: Surgical Management
785
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
Here are some common surgical interventions for IBD:
785


